TBLA compared with AGEN: revenue, margins and what each company keeps, and the suppliers and customers both name

TBLATaboola.com Ltd.

Mkt capRevenueRevenue

AGENAgenus Inc

Mkt capRevenueRevenue

Compare

TBLATaboola.com Ltd.

AGENAgenus Inc

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Supply-chain overlap

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only TBLA 1

DVDoubleVerifycustomer

Shared 0

No shared counterparties.

Only AGEN 12

—Zydus Lifesciencesunlistedcustomer

MRKMerck Sharp & Dohmecustomer

GILDGilead Sciencescustomer

BMYBristol-Myers Squibb

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

customer

8 more · AGEN chain ›

TBLATaboola.com Ltd.

2.00▼−7.83%· post 2.04

Mkt cap$532.5MRevenue$462MQ3 FY26Revenue$1.9BFY25

AGENAgenus Inc

7.13▲+10.71%· post 7.18

ClosedNov 6 '26

Mkt cap$323.5MRevenue$31MQ3 FY26Revenue$114MFY25

Compare

ClosedNov 6 '26

TBLATaboola.com Ltd.

AGENAgenus Inc

2.00▼−7.83%post 2.04

Price

7.13▲+10.71%post 7.18

$532.5M

Mkt cap

$323.5M

Q3 FY26$462M

Revenue

$31MQ3 FY26

FY25$1.9B

Revenue

$114MFY25

TBLA2.00▼−7.83%vsAGEN7.13▲+10.71%ClosedNov 6 '26